N-(2-((4-Chlorobenzyl)thio)benzo[d]thiazol-6-yl)-2-(morpholine-4-carbonyl)benzamide, 97%, 25mg

10-(4-Chlorophenyl)-5,5-difluoro-2-formyl-1,3,7,9-tetramethyl-5H-dipyrrolo[1,2-c:2',1'-f][1,3,2]diazaborinin-4-ium-5-uide, 98%, 250mg

2-(2-Hydroxyphenyl)acetonitrile, 95.0%, 1g

Methyl 5-(1H-indazol-3-yl)furan-2-carboxylate, 97%, 1g

7-Chloro-5-cyclopropyl-[1,2,4]triazolo[1,5-a]pyrimidine, 97%, 5g

N-Hydroxy-2-(trifluoromethyl)benzimidoyl chloride, 95.0%, 250mg

Symbole d'avertissement selon ISO 7010 Étiquette individuelle, Dangereux, tension électrique, Longueur de côté 200 mm, 1 pièce

Bis(4-methoxybenzyl)amine hydrochloride, 97.0%, 1g

4-(4-(8-Oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-(1,4-dioxaspiro[4.5]decan-8-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl)aniline, 98%, 25mg

6-METHOXY-1H-INDOLE-5-CARBOXYLIC ACID, 95.0%, 50mg

Methyl (3R,5S,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoate, 95%, 10g

(1-Methyl-1H-indazol-4-yl)methanol, 95.0%, 10g

2-(4-CHLOROPHENYL)-N-METHYLACETAMIDE, 95.0%, 2g